Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT00032019. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1
Conditions listed in this trial
Lymphoma
2
Additional conditions recognized in this trial
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
3
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
4
Interventions listed in this trial
cyclophosphamide
doxorubicin hydrochloride
etoposide
filgrastim
prednisone
rituximab
vincristine sulfate
5
Additional drug interventions recognized in this trial
Doxorubicin
Vincristine
6
More general drug interventions related to this trial
Alkylating Agents
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
7
Sponsors listed in this trial
Cancer and Leukemia Group B
National Cancer Institute (NCI)
U.S. National Library of Medicine
,
Contact Help Desk
U.S. National Institutes of Health
,
U.S. Department of Health & Human Services
,
USA.gov
,
Copyright
,
Privacy
,
Accessibility
,
Freedom of Information Act
Links to all studies - primarily for crawlers